At day 30 after AMI, an increase in Galectin-3 plasma concentration in the median cubital vein of 1 unit, was independently associated with the 1.55-fold (p = 0.01) increased risk of LVR, six months after AMI (Table 3), adjusted for age, leukocyte count, CRP and diabetes. Here, LGALS3 is linked to diabetes mellitus.